These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 23945905)

  • 1. Association of depression with accelerated cognitive decline among patients with type 2 diabetes in the ACCORD-MIND trial.
    Sullivan MD; Katon WJ; Lovato LC; Miller ME; Murray AM; Horowitz KR; Bryan RN; Gerstein HC; Marcovina S; Akpunonu BE; Johnson J; Yale JF; Williamson J; Launer LJ
    JAMA Psychiatry; 2013 Oct; 70(10):1041-7. PubMed ID: 23945905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the Haptoglobin Gene Polymorphism With Cognitive Function and Decline in Elderly African American Adults With Type 2 Diabetes: Findings From the Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) Study.
    Beeri MS; Lin HM; Sano M; Ravona-Springer R; Liu X; Bendlin BB; Gleason CE; Guerrero-Berroa E; Soleimani L; Launer LJ; Ehrenberg S; Lache O; Seligman YK; Levy AP
    JAMA Netw Open; 2018 Nov; 1(7):e184458. PubMed ID: 30646354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Fenofibrate Therapy With Long-term Cardiovascular Risk in Statin-Treated Patients With Type 2 Diabetes.
    Elam MB; Ginsberg HN; Lovato LC; Corson M; Largay J; Leiter LA; Lopez C; O'Connor PJ; Sweeney ME; Weiss D; Friedewald WT; Buse JB; Gerstein HC; Probstfield J; Grimm R; Ismail-Beigi F; Goff DC; Fleg JL; Rosenberg Y; Byington RP;
    JAMA Cardiol; 2017 Apr; 2(4):370-380. PubMed ID: 28030716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial.
    Cukierman-Yaffe T; Gerstein HC; Williamson JD; Lazar RM; Lovato L; Miller ME; Coker LH; Murray A; Sullivan MD; Marcovina SM; Launer LJ;
    Diabetes Care; 2009 Feb; 32(2):221-6. PubMed ID: 19171735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cross-sectional and longitudinal associations of diabetic retinopathy with cognitive function and brain MRI findings: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.
    Hugenschmidt CE; Lovato JF; Ambrosius WT; Bryan RN; Gerstein HC; Horowitz KR; Launer LJ; Lazar RM; Murray AM; Chew EY; Danis RP; Williamson JD; Miller ME; Ding J
    Diabetes Care; 2014 Dec; 37(12):3244-52. PubMed ID: 25193529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal function as an effect modifier of intensive glucose control in delaying cognitive function decline among individuals with type 2 diabetes: A revisit to the ACCORD MIND trial.
    Li P; Kianmehr H; Guan D; Kulshreshtha A; Narayan KMV; Ali MK; Umpierrez GE; Hu X; Fonseca VA; Shi L; Shao H
    Diabetes Obes Metab; 2024 Sep; 26(9):3958-3968. PubMed ID: 38962812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy.
    Launer LJ; Miller ME; Williamson JD; Lazar RM; Gerstein HC; Murray AM; Sullivan M; Horowitz KR; Ding J; Marcovina S; Lovato LC; Lovato J; Margolis KL; O'Connor P; Lipkin EW; Hirsch J; Coker L; Maldjian J; Sunshine JL; Truwit C; Davatzikos C; Bryan RN;
    Lancet Neurol; 2011 Nov; 10(11):969-77. PubMed ID: 21958949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent Effects of Intensive Glycemic Control on Retinopathy in Type 2 Diabetes in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Follow-On Study.
    Action to Control Cardiovascular Risk in Diabetes Follow-On (ACCORDION) Eye Study Group and the Action to Control Cardiovascular Risk in Diabetes Follow-On (ACCORDION) Study Group
    Diabetes Care; 2016 Jul; 39(7):1089-100. PubMed ID: 27289122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of basal insulin glargine and omega-3 fatty acid on cognitive decline and probable cognitive impairment in people with dysglycaemia: a substudy of the ORIGIN trial.
    Cukierman-Yaffe T; Bosch J; Diaz R; Dyal L; Hancu N; Hildebrandt P; Lanas F; Lewis BS; Marre M; Yale JF; Yusuf S; Gerstein HC;
    Lancet Diabetes Endocrinol; 2014 Jul; 2(7):562-72. PubMed ID: 24898834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia.
    Yaffe K; Falvey C; Hamilton N; Schwartz AV; Simonsick EM; Satterfield S; Cauley JA; Rosano C; Launer LJ; Strotmeyer ES; Harris TB
    Arch Neurol; 2012 Sep; 69(9):1170-5. PubMed ID: 22710333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of Baseline Diastolic Blood Pressure on the Effects of Systolic Blood Pressure Lowering on Cognitive Function in Type 2 Diabetes Mellitus.
    Gupta A; Boucher R; Wei G; Gronseth G; Parks A; Beddhu S
    Am J Hypertens; 2023 Feb; 36(2):120-125. PubMed ID: 36227718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: post hoc epidemiologic analysis of the ACCORD trial.
    Punthakee Z; Miller ME; Launer LJ; Williamson JD; Lazar RM; Cukierman-Yaffee T; Seaquist ER; Ismail-Beigi F; Sullivan MD; Lovato LC; Bergenstal RM; Gerstein HC; ;
    Diabetes Care; 2012 Apr; 35(4):787-93. PubMed ID: 22374637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of Early Kidney Disease With Brain Magnetic Resonance Imaging and Cognitive Function in African Americans With Type 2 Diabetes Mellitus.
    Freedman BI; Sink KM; Hugenschmidt CE; Hughes TM; Williamson JD; Whitlow CT; Palmer ND; Miller ME; Lovato LC; Xu J; Smith SC; Launer LJ; Barzilay JI; Cohen RM; Sullivan MD; Bryan RN; Wagner BC; Bowden DW; Maldjian JA; Divers J;
    Am J Kidney Dis; 2017 Nov; 70(5):627-637. PubMed ID: 28648301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "If it ain't broke, don't fix it": a commentary on the positive-negative results of the ACCORD Lipid study.
    Tenenbaum A; Fisman EZ
    Cardiovasc Diabetol; 2010 Jun; 9():24. PubMed ID: 20550659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Relationship Between the Score on a Simple Measure of Cognitive Function and Incident CVD in People With Diabetes: A Post Hoc Epidemiological Analysis From the ACCORD-MIND Study.
    Cukierman-Yaffe T; Gerstein HC; Miller ME; Launer LJ; Williamson JD; Horowitz KR; Ismail-Beigi F; Lazar RM
    J Clin Endocrinol Metab; 2017 Sep; 102(9):3218-3225. PubMed ID: 28575229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe hypoglycaemia and late-life cognitive ability in older people with Type 2 diabetes: the Edinburgh Type 2 Diabetes Study.
    Aung PP; Strachan MW; Frier BM; Butcher I; Deary IJ; Price JF;
    Diabet Med; 2012 Mar; 29(3):328-36. PubMed ID: 22023662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: the ACCORD randomized trial.
    Margolis KL; O'Connor PJ; Morgan TM; Buse JB; Cohen RM; Cushman WC; Cutler JA; Evans GW; Gerstein HC; Grimm RH; Lipkin EW; Narayan KM; Riddle MC; Sood A; Goff DC
    Diabetes Care; 2014 Jun; 37(6):1721-8. PubMed ID: 24595629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment: The Action to Control Cardiovascular Risk in Diabetes Study.
    Papademetriou V; Lovato L; Tsioufis C; Cushman W; Applegate WB; Mottle A; Punthakee Z; Nylen E; Doumas M;
    Am J Nephrol; 2017; 45(2):136-145. PubMed ID: 27992863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase in Number of Depression Symptoms Over Time is Related to Worse Cognitive Outcomes in Older Adults With Type 2 Diabetes.
    Ravona-Springer R; Heymann A; Lin HM; Liu X; Berman Y; Schwartz J; Soleimani L; Sano M; Beeri MS
    Am J Geriatr Psychiatry; 2021 Jan; 29(1):1-11. PubMed ID: 33127316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.